These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 3011675

  • 1. A preclinical evaluation of aminopyridines as putative therapeutic agents in the treatment of botulism.
    Simpson LL.
    Infect Immun; 1986 Jun; 52(3):858-62. PubMed ID: 3011675
    [Abstract] [Full Text] [Related]

  • 2. Ineffectiveness of 3,4-diaminopyridine as a therapy for type C botulism.
    Siegel LS, Price JI.
    Toxicon; 1987 Jun; 25(9):1015-8. PubMed ID: 3433299
    [Abstract] [Full Text] [Related]

  • 3. Use of pharmacologic antagonists to deduce commonalities of biologic activity among clostridial neurotoxins.
    Simpson LL.
    J Pharmacol Exp Ther; 1988 Jun; 245(3):867-72. PubMed ID: 2455038
    [Abstract] [Full Text] [Related]

  • 4. Effect of 3,4-diaminopyridine on the survival of mice injected with botulinum neurotoxin type A, B, E, or F.
    Siegel LS, Johnson-Winegar AD, Sellin LC.
    Toxicol Appl Pharmacol; 1986 Jun 30; 84(2):255-63. PubMed ID: 3715874
    [Abstract] [Full Text] [Related]

  • 5. The action of batulinum toxin at the neuromuscular junction.
    Sellin LC.
    Med Biol; 1981 Feb 30; 59(1):11-20. PubMed ID: 6115105
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the action of types A and F botulinum toxin at the rat neuromuscular junction.
    Kauffman JA, Way JF, Siegel LS, Sellin LC.
    Toxicol Appl Pharmacol; 1985 Jun 30; 79(2):211-7. PubMed ID: 2988154
    [Abstract] [Full Text] [Related]

  • 7. Lectins from Triticum vulgaris and Limax flavus are universal antagonists of botulinum neurotoxin and tetanus toxin.
    Bakry N, Kamata Y, Simpson LL.
    J Pharmacol Exp Ther; 1991 Sep 30; 258(3):830-6. PubMed ID: 1653841
    [Abstract] [Full Text] [Related]

  • 8. Aminopyridines Restore Ventilation and Reverse Respiratory Acidosis at Late Stages of Botulism in Mice.
    McClintic WT, Chandler ZD, Karchalla LM, Ondeck CA, O'Brien SW, Campbell CJ, Jacobson AR, McNutt PM.
    J Pharmacol Exp Ther; 2024 Jan 17; 388(2):637-646. PubMed ID: 37977816
    [Abstract] [Full Text] [Related]

  • 9. 3,4-diaminopyridine reverses paralysis in botulinum neurotoxin-intoxicated diaphragms through two functionally distinct mechanisms.
    Bradford AB, Machamer JB, Russo TM, McNutt PM.
    Toxicol Appl Pharmacol; 2018 Feb 15; 341():77-86. PubMed ID: 29366638
    [Abstract] [Full Text] [Related]

  • 10. Exchanging the minimal cell binding fragments of tetanus neurotoxin in botulinum neurotoxin A and B impacts their toxicity at the neuromuscular junction and central neurons.
    Höltje M, Schulze S, Strotmeier J, Mahrhold S, Richter K, Binz T, Bigalke H, Ahnert-Hilger G, Rummel A.
    Toxicon; 2013 Dec 01; 75():108-21. PubMed ID: 23817019
    [Abstract] [Full Text] [Related]

  • 11. Symptomatic relief of botulinum neurotoxin/a intoxication with aminopyridines: a new twist on an old molecule.
    Mayorov AV, Willis B, Di Mola A, Adler D, Borgia J, Jackson O, Wang J, Luo Y, Tang L, Knapp RJ, Natarajan C, Goodnough MC, Zilberberg N, Simpson LL, Janda KD.
    ACS Chem Biol; 2010 Dec 17; 5(12):1183-91. PubMed ID: 20936877
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of vacuolar adenosine triphosphatase antagonizes the effects of clostridial neurotoxins but not phospholipase A2 neurotoxins.
    Simpson LL, Coffield JA, Bakry N.
    J Pharmacol Exp Ther; 1994 Apr 17; 269(1):256-62. PubMed ID: 8169833
    [Abstract] [Full Text] [Related]

  • 13. Different effects of types A and B botulinum toxin on transmitter release at the rat neuromuscular junction.
    Sellin LC, Thesleff S, Dasgupta BR.
    Acta Physiol Scand; 1983 Apr 17; 119(2):127-33. PubMed ID: 6140815
    [Abstract] [Full Text] [Related]

  • 14. Neuromuscular paralysis and recovery in mice injected with botulinum neurotoxins A and C.
    Morbiato L, Carli L, Johnson EA, Montecucco C, Molgó J, Rossetto O.
    Eur J Neurosci; 2007 May 17; 25(9):2697-704. PubMed ID: 17561839
    [Abstract] [Full Text] [Related]

  • 15. Tetanus toxin blocks the neuromuscular transmission in vitro like botulinum A toxin.
    Habermann E, Dreyer F, Bigalke H.
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Feb 17; 311(1):33-40. PubMed ID: 6245375
    [No Abstract] [Full Text] [Related]

  • 16. Recovery from botulinum neurotoxin poisoning in vivo.
    Keller JE.
    Neuroscience; 2006 May 12; 139(2):629-37. PubMed ID: 16490322
    [Abstract] [Full Text] [Related]

  • 17. Botulinum and Tetanus Neurotoxin-Induced Blockade of Synaptic Transmission in Networked Cultures of Human and Rodent Neurons.
    Beske PH, Bradford AB, Grynovicki JO, Glotfelty EJ, Hoffman KM, Hubbard KS, Tuznik KM, McNutt PM.
    Toxicol Sci; 2016 Feb 12; 149(2):503-15. PubMed ID: 26615023
    [Abstract] [Full Text] [Related]

  • 18. Chelation of zinc antagonizes the neuromuscular blocking properties of the seven serotypes of botulinum neurotoxin as well as tetanus toxin.
    Simpson LL, Coffield JA, Bakry N.
    J Pharmacol Exp Ther; 1993 Nov 12; 267(2):720-7. PubMed ID: 8246147
    [Abstract] [Full Text] [Related]

  • 19. Human type A botulism and treatment with 3,4-diaminopyridine.
    Davis LE, Johnson JK, Bicknell JM, Levy H, McEvoy KM.
    Electromyogr Clin Neurophysiol; 1992 Nov 12; 32(7-8):379-83. PubMed ID: 1526219
    [Abstract] [Full Text] [Related]

  • 20. Antidotal treatment of botulism in rats by continuous infusion with 3,4-diaminopyridine.
    Machamer JB, Vazquez-Cintron EJ, O'Brien SW, Kelly KE, Altvater AC, Pagarigan KT, Dubee PB, Ondeck CA, McNutt PM.
    Mol Med; 2022 Jun 03; 28(1):61. PubMed ID: 35659174
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.